TRDMT1 and osteosarcoma: Moreover, redox homeostasis, proliferation-related pathways, and DNMT2/TRDMT1-based effects could be modulated as part of an anti-osteosarcoma strategy, reflecting the diverse phenotypic features of osteosarcoma cells [116].